**Core Concept**
The question is testing the understanding of a specific ECG pattern and the corresponding drug contraindication in a patient with a certain condition. The underlying principle is the recognition of the ECG pattern and the knowledge of the pharmacological effect of the mentioned drugs on the heart.

**Why the Correct Answer is Right**
The ECG pattern described is likely to be a long QT interval, which is a risk factor for Torsades de Pointes, a potentially life-threatening arrhythmia. The drug that should not be given in this condition is a Class III anti-arrhythmic agent, such as Ibutilide or Dofetilide, which can further prolong the QT interval and increase the risk of Torsades de Pointes. These drugs work by blocking potassium channels, which can lead to a prolongation of the QT interval.

**Why Each Wrong Option is Incorrect**
**Option A:** Digoxin is a Class IA anti-arrhythmic agent, which is not a contraindication in this condition. It works by blocking sodium channels and increasing the contractility of the heart.
**Option B:** Amiodarone is a Class III anti-arrhythmic agent, but it is used to treat and prevent arrhythmias, including Torsades de Pointes, in patients with a long QT interval. It has a more complex mechanism of action, which includes blocking sodium, calcium, and potassium channels.
**Option C:** Verapamil is a calcium channel blocker, which is not a contraindication in this condition. It works by blocking calcium channels and reducing the contractility of the heart.

**Clinical Pearl / High-Yield Fact**
In patients with a long QT interval, it is essential to avoid Class III anti-arrhythmic agents, such as Ibutilide or Dofetilide, as they can further prolong the QT interval and increase the risk of Torsades de Pointes. Instead, beta-blockers, such as Propranolol or Sotalol, may be used to treat and prevent arrhythmias in these patients.

**Correct Answer:** .